Ian Bothwell

Ian Bothwell is currently the Chief Executive Officer and Chief Financial Officer and a member of the Board of Directors of ZEO ScientifiX, Inc., a publicly traded clinical-stage biopharmaceutical company (OTCQB “ZEOX”) focused on the research and development of biological therapeutic platforms and is currently positioning itself to be a leading provider of stem cell products for physicians in Florida that comply with the regulations of the new Florida legislation SB 1768.

Posts by Ian Bothwell

MedCity Influencers

Florida’s New Stem Cell Law: What It Signals for Physicians, Patients and the Future of Regenerative Medicine

You don’t have to practice in Florida for this law to matter. Patient interest in regenerative care is growing rapidly, and physicians across the country need to be prepared to understand and consider advising patients, where applicable, of these stem cell-related treatment options.

Ian Bothwell

Posts by Ian Bothwell

Florida’s New Stem Cell Law: What It Signals for Physicians, Patients and the Future of Regenerative Medicine

Payment Integrity is a Systems Problem, not a Data Glitch

ChatGPT for Medical Use Is a Cry for Help. We Need Better Medical Triage

Healthcare Experts Slam Florida’s Plan to End Vaccine Mandates